Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - iron as iron dextran; vitamin a palmitate; vitamin d3 = cholecalciferol; tocopheryl acetate (vitamin e) - parenteral liquid/solution/suspension - iron as iron dextran mineral-iron active 100.0 mg/ml; vitamin a palmitate vitamin-a other 10000.0 iu/ml; vitamin d3 = cholecalciferol vitamin-d3 other 1000.0 iu/ml; tocopheryl acetate (vitamin e) vitamin-e other 10.0 mg/l - nutrition & metabolism - pig - piglet | neonatal piglet | new born pig | sucker pig - iron supplement

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - retinol as the palmitate; vitamin d3 = cholecalciferol; alpha tocopherol acetate (vitamin e) as vitamin e adsorb - parenteral liquid/solution/suspension - retinol as the palmitate vitamin-a active 500000.0 iu/ml; vitamin d3 = cholecalciferol vitamin-d3 active 50000.0 iu/ml; alpha tocopherol acetate (vitamin e) as vitamin e adsorb vitamin-e active 50.0 mg - nutrition & metabolism - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - vitamin a deficiency | vitamin d deficiency | vitamin e deficiency

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

the hunter river company pty limited - vitamin a palmitate; cholecalciferol; alpha-tocopheryl (vitamin e) - parenteral liquid/solution/suspension - vitamin a palmitate vitamin-a active 294.0 mg/ml; cholecalciferol vitamin-d3 active 1.25 mg/ml; alpha-tocopheryl (vitamin e) vitamin-e active 50.0 mg/ml - nutrition & metabolism

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ausrichter pty ltd - vitamin a palmitate; vitamin c = ascorbic acid; vitamin d3 = cholecalciferol; vitamin e-d alpha acetate = alpha tocopheryl-d acetate - parenteral liquid/solution/suspension - vitamin a palmitate vitamin-a active 29.42 mg/ml; vitamin c = ascorbic acid vitamin-c active 100.0 mg/ml; vitamin d3 = cholecalciferol vitamin-d3 active 0.625 mg/ml; vitamin e-d alpha acetate = alpha tocopheryl-d acetate vitamin-e active 30.0 mg/ml - nutrition & metabolism - dog | horse | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at - vitamin | biotin deficiencies | detoxifying agent | erythropoietic activity | stamina | vitamin a | vitamin b | vitamin c | vitamin d | vitamin deficiencies | vitamin e | vitamin k

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ultimate equine ltd - selenium amino acid chelate; chromium amino acid chelate; betacarotene & retinyl palmitate - vitamin-a activity; vitamin d3 = cholecalciferol; dl-alpha-tocopheryl acetate (vitamin e) - oral powder, pre-mix - selenium amino acid chelate chelating agent-mineral active 0.63 mg/do; chromium amino acid chelate chelating agent-mineral active 5.0 mg/do; betacarotene & retinyl palmitate - vitamin-a activity vitamin-a active 6000.0 i.u.; vitamin d3 = cholecalciferol vitamin-d3 active 2000.0 iu/d; dl-alpha-tocopheryl acetate (vitamin e) vitamin-e active 500.0 mg - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies

États-Unis - anglais - NLM (National Library of Medicine)

sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 80 mg in 4 ml - infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite pediatric is contraindicated in patients who have: infuvite pediatric has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. animal reproduction studies have not been conducted with infuvite pediatric (multiple vitamins injection). infuvite pediatric has not been studied in nursing mothers. lactating women may have vitamin requirements that exceed those of non-lactating women. caution should be exercised when infuvite pediatric is administered to nursing mothers. infuvite pediatric is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years

États-Unis - anglais - NLM (National Library of Medicine)

sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite pediatric is contraindicated in patients who have: infuvite pediatric has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. animal reproduction studies have not been conducted with infuvite pediatric (multiple vitamins injection). infuvite pediatric has not been studied in nursing mothers. lactating women may have vitamin requirements that exceed those of non-lactating women. caution should be exercised when infuvite pediatric is administered to nursing mothers. infuvite pediatric is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years

États-Unis - anglais - NLM (National Library of Medicine)

sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 80 mg in 4 ml - infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite pediatric is contraindicated in patients who have: infuvite pediatric has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. animal reproduction studies have not been conducted with infuvite pediatric (multiple vitamins injection). infuvite pediatric has not been studied in nursing mothers. lactating women may have vitamin requirements that exceed those of non-lactating women. caution should be exercised when infuvite pediatric is administered to nursing mothers. infuvite pediatric is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years

États-Unis - anglais - NLM (National Library of Medicine)

sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 200 mg in 10 ml - infuvite adult is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite adult is contraindicated in patients who have infuvite adult has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for their condition, because their vitamin requirements may exceed those of nonpregnant women. animal reproduction studies have not been conducted with infuvite adult. infuvite adult has not been studied in lactating women.lactating women should follow the u.s. recommended daily allowances for their condition, because their vitamin requirement may exceed those of nonlactating women. caution should be exercised when infuvite adult is administered to a nursing mother. safety and effectiveness in children below the age of 11 years have not been establish

États-Unis - anglais - NLM (National Library of Medicine)

sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 200 mg in 10 ml - infuvite adult is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite adult is contraindicated in patients who have infuvite adult has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for their condition, because their vitamin requirements may exceed those of nonpregnant women. animal reproduction studies have not been conducted with infuvite adult. infuvite adult has not been studied in lactating women.lactating women should follow the u.s. recommended daily allowances for their condition, because their vitamin requirement may exceed those of nonlactating women. caution should be exercised when infuvite adult is administered to a nursing mother. safety and effectiveness in children below the age of 11 years have not been establish